SEB Sweden Equity Fund Surpasses Benchmark in July, Swedbank, Epiroc, Novo Nordisk, and Asker Healthcare Lead Net Buys

The SEB Sweden Equity Fund C SEK rose 2.0% in July, outperforming its benchmark index, with technology and real estate sectors contributing positively. The biggest positive contributors were Hexagon, Beijer Ref, Astra Zeneca, and Traton, while Novo Nordisk, Addlife, Asker Healthcare, and Sweco weighed on returns. The fund's largest net purchases were in Swedbank, Epiroc, Novo Nordisk, and Asker Healthcare.